Author:
Zhang Pingye,Li Xiaoyun Nicole,Lu Kaifeng,Wu Chengqing
Subject
Pharmacology (medical),General Medicine
Reference11 articles.
1. The drug-dosing conundrum in oncology - when less is more;Shah;N. Engl. J. Med.,2021
2. PI3K Inhibitors in Hematologic Malignancies ODAC Briefing Document. FDA. https://www.fda.gov/media/157762/download/. (Accessed April 21, 2022).
3. A 2-in-1 adaptive phase 2/3 design for expedited oncology drug development;Chen;Contemp. Clin. Trials.,2018
4. Extensions of the 2-in-1 adaptive design;Chen;Contemp. Clin. Trials.,2020
5. The extension of 2-in-1 adaptive phase 2/3 designs and its application in oncology clinical trials;Fan;Contemp. Clin. Trials.,2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献